Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Endologix
With
Fivos
Evaluate the clinical performance of the AFX2 System patients against other commercially available EVAR devices and evaluate the Type III endoleak occurrence in AFX2 System patients through 5 years.
Age
Any age
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
All patients implanted with the AFX2 System or the 3 most commonly used comparator devices who underwent EVAR as their first abdominal aortic aneurysm repair in the VQI EVAR registry will be included in this study.
You may not be if
Ruptured AAA repair with the AFX2 or comparator device
Patients with AFX2 in AFX relining, or relined comparator grafts.